Acordo-Quadro para Conjunto de Medicamentos do aparelho cardiovascular, na área da saúde

ID 10700398 · Portal BASE
Price
Base Price
€72,517 .00
Effective Price
€6 .00 -100.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33622000
Location
Portugal, Lisboa, Lisboa
Bidder Count
23
Winner
SANDOZ FARMACÊUTICA LDA
NIF 506985261
Company
Competition
23 bidders recorded
LOGIFARMA - LOGÍSTICA FARMACÊUTICA S.A.
NIF 503934640
SPC - SOUTH POINT CARE - ESPECIALIDADES FARMACÊUTICAS, LDA.
NIF 508284872
Eqyon Healthcare Solutions, Lda
NIF 516338021
B.BRAUN MEDICAL LDA
NIF 501506543
NOVARTIS FARMA - PRODUTOS FARMACÊUTICOS S.A.
NIF 500063524
BAXTER - MÉDICO FARMACÊUTICA, LDA
NIF 503347345
ANGELINI FARMACÊUTICA, LDA.
NIF 500583650
BAYER PORTUGAL, LDA
NIF 500043256
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
ORIONFIN Unipessoal, Lda
NIF 508907365
ACCORD HEALTHCARE, UNIPESSOAL LDA
NIF 508622263
Hikma Farmaceutica, lda
NIF 502266791
GENERIS - FARMACÊUTICA, S.A.
NIF 508107997
SANDOZ FARMACÊUTICA LDA
NIF 506985261
LABORATÓRIOS PFIZER LDA
NIF 500162166
FERRAZ, LYNCE, ESPECIALIDADES FARMACÊUTICAS, S.A.
NIF 500113270
PHARMAKERN PORTUGAL, LDA.
NIF 507002571
BIOJAM SA
NIF 513642749
Accord Healthcare, Unipessoal (508622263), Takeda Farmacêuticos Portugal, Lda (502801204), GlaxoSmithKline - Produtos Farmacêuticos, Lda (500139962), Hikma Farmaceutica (Portugal) Lda (502266791), LAB. PFIZER, LDA. (500162166), Zentiva Portugal, Lda.
NIF 503103551
LABESFAL - LABORATÓRIOS ALMIRO S.A.
NIF 501169580
OVERPHARMA - PRODUTOS MÉDICOS E FARMACÊUTICOS LDA
NIF 505792362
Bluepharma
NIF 506037169
LABORATORIO MEDINFAR-PRODUTOS FARMACEUTICOS S.A.
NIF 500384045
Dates
Publication
06 May 2024
Celebration
24 Apr 2024
Contracting Entity
LM - Laboratório Nacional do Medicamento
NIF 600087581
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 85 · HIGH RISK
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
06 May 2024
Signing Date
24 Apr 2024
Days Late
12
Rule
A2/A3 late publication: 12 days after signing (threshold: 10)
Detected 2026-03-06
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
72517.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
72517.0
Total effective price
6.0
Ratio
0.0001
Direction
reduction
Rule
A9 price reduction: ratio 0.0001 outside [0.5, 1.5]
Detected 2026-03-06